News, Articles and Updates
News
VA eyes psychedelic treatment for up to 2.1 million veterans with mental illness
The Department of Veterans Affairs is preparing to expand access to psychedelic therapies for veterans with mental health conditions, with as many as 2.1 million potentially benefiting from the treatments, according to an Oct. 25 report from Politico. Andrew Gradison, a senior adviser at the…
1 in 3 young adults use AI for substance-related information: 5 notes
Nearly 1 in 3 young adults in the U.S. reported using generative AI to seek substance-related information, with higher rates of use among Black and male respondents, according to a study published Oct. 19 in JMIR Formative Research. Researchers at Rutgers, the State University of…
8 Companies to Watch for a Potential Sale in 2027
Dealmaking across the behavioral health industry continues to face challenges. However, no single thing explains the relative disquiet in behavioral health dealmaking. Several industry sources are also looking at the dealmaking environment and seeing its underlying strengths and weaknesses. But many industry insiders Behavioral Health…
Daridorexant, Orexin Receptor Agonist, Shows Positive Results in Pediatric Insomnia
Phase 2 trial shows daridorexant boosts pediatric insomnia sleep time up to 50 minutes, including ADHD/ASD patients, with strong safety and phase 3 plans. — From Psychiatric Times articles Read More
Washington State University lands $7.5M to study kratom for chronic pain
Pullman, Wash.-based Washington State University received a $7.5 million grant from the National Institutes of Health to study the effects of kratom on chronic pain, sleep and quality of life. The five-year project will examine how kratom works, its potential benefits and associated risks, according…
How a VA hospital cut behavioral incidents 35% without medication
The geriatric inpatient mental health unit at Oklahoma City VA Health Care System reduced behavioral reports by 35% during the first year of implementing nonpharmacological interventions for veterans with dementia, according to a July 2026 American Hospital Association case study. The reduction followed the unit’s…
RFK Jr. bypasses NIH director’s pick to lead mental health institute: Report
HHS Secretary Robert F. Kennedy Jr. reportedly favors Stanford (Calif.) University psychiatrist Shebani Sethi, MD, PhD, to lead the National Institute of Mental Health, bypassing a candidate recommended by National Institutes of Health Director Jay Bhattacharya, MD, PhD, Science reported Oct. 23. Dr. Bhattacharya had…
Synapse-Level Mapping Could Reveal How Disrupted Brain Circuits Lead to Psychiatric Disorders
New automated connectomics maps synapses across circuits, revealing how inhibitory neuron subtypes shape decision-making and may explain circuit dysfunction in psychiatric disorders. — From Psychiatric Times articles Read More
Potential depression subtype tied to poorer antidepressant response: Study
Researchers have identified evidence supporting a potential subtype of clinical depression, known as “circadian depression,” defined by disrupted sleep-wake patterns and associated with more severe symptoms and poorer responses to commonly prescribed antidepressants, according to a study published Oct. 20 in The British Journal of…
How 3 health systems are rethinking high-utilization ED patients
A patient who comes back to the emergency department repeatedly is often bringing more than a medical problem. Unstable housing, mental health and substance use challenges, food insecurity, unreliable transportation and trouble getting follow-up care can all send individuals back through the ED. These are…
Revisiting MDD Management in Primary Care
Two decades after a landmark STAR*D trial recalibrated expectations, Dr. DeBattista argues the standard of care has barely moved, and that measurement-based care remains the underused lever. — From Psychiatric Times articles Read More
MDD Side Effect Profiles: Counseling, Adherence, and Suicidality Monitoring
The side effect that stops the drug is usually the one nobody warned about. The panel works through what belongs in the first conversation and how often to reassess for suicidality. — From Psychiatric Times articles Read More
Integrated Psychiatric Consultants
Office Hours:Mon-Fri, 9 a.m. - 5 p.m. CT